ZIOPHARM Oncology Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
68,204.00
42,803.00
140,717.00
81,053.00
70,946.00
61,729
Total Accounts Receivable
145.00
145.00
446.00
21.00
19.00
1,864
Other Current Assets
1,948.00
1,139.00
11,358.00
23,810.00
19,818.00
20,692
Total Current Assets
70,297.00
44,087.00
152,521.00
104,884.00
90,783.00
84,285
Net Property, Plant & Equipment
801.00
531.00
581.00
843.00
1,211.00
1,097
Total Investments and Advances
-
491.00
620.00
620.00
104.00
105
Other Assets
656.00
128.00
2.00
1.00
13,508.00
9,564
Total Assets
71,754.00
45,237.00
153,724.00
106,348.00
105,606.00
95,051
Accounts Payable
422.00
2,004.00
2,008.00
156.00
4,417.00
Other Current Liabilities
7,369.00
8,822.00
16,115.00
15,653.00
16,439.00
Total Current Liabilities
7,791.00
10,826.00
18,123.00
15,809.00
20,856.00
Other Liabilities
14,580.00
570.00
48,230.00
42,516.00
37,564.00
Total Liabilities
22,371.00
11,396.00
66,353.00
58,325.00
58,420.00
Common Equity (Total)
49,383.00
33,841.00
87,371.00
77,298.00
96,806.00
Total Shareholders' Equity
49,383.00
33,841.00
87,371.00
48,023.00
47,186.00
Total Equity
49,383.00
33,841.00
87,371.00
48,023.00
47,186.00
Liabilities & Shareholders' Equity
71,754.00
45,237.00
153,724.00
106,348.00
105,606.00
Preferred Stock (Carrying Value)
-
-
-
125,321.00
143,992.00
About ZIOPHARM Oncology
View Profile
